ARB | MARB | ARB / MARB | |
Gain YTD | 5.449 | 4.274 | 127% |
Net Assets | 88.5M | 33.5M | 264% |
Total Expense Ratio | 0.84 | 1.74 | 48% |
Turnover | 431.00 | 301.00 | 143% |
Yield | 1.07 | 3.37 | 32% |
Fund Existence | 5 years | 6 years | - |
ARB | MARB | |
---|---|---|
RSI ODDS (%) | 3 days ago33% | 3 days ago59% |
Stochastic ODDS (%) | 3 days ago32% | 3 days ago47% |
Momentum ODDS (%) | 3 days ago63% | 3 days ago56% |
MACD ODDS (%) | N/A | 3 days ago55% |
TrendWeek ODDS (%) | 3 days ago59% | 3 days ago50% |
TrendMonth ODDS (%) | 3 days ago55% | 3 days ago47% |
Advances ODDS (%) | 5 days ago57% | 13 days ago51% |
Declines ODDS (%) | 13 days ago36% | 26 days ago50% |
BollingerBands ODDS (%) | 5 days ago30% | 3 days ago51% |
Aroon ODDS (%) | 3 days ago46% | 3 days ago55% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTCX | 26.00 | 0.23 | +0.89% |
Fidelity Advisor Biotechnology C | |||
DCINX | 20.73 | 0.13 | +0.63% |
Dunham International Stock C | |||
RISRX | 14.37 | 0.05 | +0.35% |
RBC International Small Cap Equity R6 | |||
FIQPX | 67.94 | 0.19 | +0.28% |
Fidelity Advisor Emerging Asia Z | |||
PMYCX | 45.79 | 0.04 | +0.09% |
Putnam Core Equity Fund C |
A.I.dvisor tells us that MARB and IRBT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MARB and IRBT's prices will move in lockstep.
Ticker / NAME | Correlation To MARB | 1D Price Change % | ||
---|---|---|---|---|
MARB | 100% | -0.34% | ||
IRBT - MARB | 32% Poorly correlated | +5.76% | ||
FHN - MARB | 32% Poorly correlated | +0.40% | ||
KIM - MARB | 26% Poorly correlated | +0.51% | ||
TGNA - MARB | 24% Poorly correlated | -0.89% | ||
PFS - MARB | 23% Poorly correlated | +1.08% | ||
More |